Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection in the Elderly”

1,207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,207 results

Early research (Phase 1)Study completedNCT06224608
What this trial is testing

Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 60
Not applicableLooking for participantsNCT07350785
What this trial is testing

Prediction of Mortality and Morbidity After Hip Fracture Using Monocyte Distribution Width (MDW)

Who this might be right for
SepsisOsteoporotic Hip FractureHip Fracture
National and Kapodistrian University of Athens 100
Testing effectiveness (Phase 2)Study completedNCT00377585
What this trial is testing

Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population

Who this might be right for
Influenza
GlaxoSmithKline 3,350
Post-approval studies (Phase 4)UnknownNCT04875858
What this trial is testing

Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients

Who this might be right for
Pneumococcal Infections
Korea University Guro Hospital 254
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Early research (Phase 1)Study completedNCT03425149
What this trial is testing

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

Who this might be right for
Zika VirusZika Virus Infection
Valneva Austria GmbH 67
Not applicableStudy completedNCT05465785
What this trial is testing

A Clinical Trial of Immuno-bridging Between Different Manufacture Scales of Recombinant COVID-19 Vaccine (Sf9 Cell)

Who this might be right for
COVID-19SARS-CoV-2 Pneumonia
WestVac Biopharma Co., Ltd. 1,000
Testing effectiveness (Phase 2)Study completedNCT02946190
What this trial is testing

The PertADO Geneva Trial

Who this might be right for
Pertussis
Siegrist Claire-Anne 60
Early research (Phase 1)Not Yet RecruitingNCT07374510
What this trial is testing

Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Sinovac Life Sciences Co., Ltd. 150
Not applicableStudy completedNCT06381843
What this trial is testing

A Clinical Study to Evaluate the Safety and Immunogenicity of the Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00170443
What this trial is testing

Trivalent rHA Dose Escalation Study in Elderly Subjects

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 399
Testing effectiveness (Phase 2)Study completedNCT05734040
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Who this might be right for
Influenza
Osivax 478
Testing effectiveness (Phase 2)Study completedNCT00776438
What this trial is testing

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

Who this might be right for
InfluenzaOrthomyxovirus InfectionsMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 160
Large-scale testing (Phase 3)Study completedNCT02214225
What this trial is testing

Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

Who this might be right for
Influenza, Human
Seqirus 3,484
Post-approval studies (Phase 4)Study completedNCT00411697
What this trial is testing

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Who this might be right for
Hepatitis B
GlaxoSmithKline 301
Testing effectiveness (Phase 2)Study completedNCT01625689
What this trial is testing

Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine

Who this might be right for
Influenza
PATH Vaccine Solutions 309
Testing effectiveness (Phase 2)Study completedNCT04677660
What this trial is testing

TAK-919 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Coronavirus Disease (COVID-19)
Takeda 200
Early research (Phase 1)UnknownNCT06205524
What this trial is testing

Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

Who this might be right for
COVID-19COVID-19 Immunisation
National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College 100
Post-approval studies (Phase 4)Study completedNCT04364399
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Mumps Vaccine

Who this might be right for
Mumps
Sinovac (Dalian) Vaccine Technology Co., Ltd. 920
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Next Page